SMTL ID : 4mdq.1

Structure of a novel submicromolar MDM2 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

2 x 28W: 3-[(1R)-2-(benzylamino)-1-{[(2S)-1-(hydroxyamino)-4-methyl-1-oxopentan-2-yl]amino}-2-oxoethyl]-6-chloro-N-hydroxy-1H-indole-2-carboxamide(Non-covalent)

28W.1: 11 residues within 4Å: Chain A: L.30, F.31, G.34, I.37, Y.43, Q.48, F.67, V.69, H.72, I.75 Ligands: 28W.2 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.30, A:Y.43, A:V.69, A:H.72, A:I.75 Hydrogen bonds: A:L.30, A:G.34 pi-Stacking: A:H.72 28W.2: 8 residues within 4Å: Chain A: M.26, K.27, L.30, H.72, R.73, Y.76, I.79 Ligands: 28W.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:M.26, A:L.30, A:Y.76, A:Y.76, A:I.79 Hydrogen bonds: A:K.27 Water bridges: A:K.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bista, M. et al., Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction. Structure (2013)

Release Date

2013-11-13

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2